Condition: Morbid Obesity · Pregnancy · Sponsor: University of Maryland, Baltimore
The goal of this randomized control trial is to compare different doses of Misoprostol (25 mcg vs 50 mcg) in induction of labor (IOL) in morbidly obese patients with BMI \>40. It is known that morbid obesity is a risk factor for failed IOL and ultimately cesarean delivery (CD.) If the rates of vaginal delivery in this population can improve, then surgical morbidity can be reduced in these patients.
This description comes directly from the study's public registry record.
Rosa Drummond, MD · 4103285965 · rosa.drummond@umm.edu
Krista Mehlhaff, DO · 4103285965 · KMehlhaff@som.umaryland.edu
Always discuss trial participation with your own doctor first.
| University of Maryland Medical Center | Baltimore, Maryland, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06199154